As COVID Rules Ease, Common Colds Rebound Across America
FRIDAY, June 25, 2021 -- Infectious disease expert Ravina Kullar ' s husband has a cold. So does her sister-in-law.
Meanwhile, the Cleveland Clinic ' s waiting rooms are becoming much more frequented by folks with coughs, sneezes and sniffles, said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 25, 2021 Category: General Medicine Source Type: news
Common cold combats COVID-19
A new Yale-led study finds that immune system activity jump-started by rhinovirus exposure could prevent or treat the early stages of COVID-19 infection. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 15, 2021 Category: Universities & Medical Training Source Type: news
Exposure to the common cold CAN protect against coronavirus, Yale study finds
Getting a cold can prime the immune system to protect you against COVID, a new study from Yale finds. The immune system response could be the start of a COVID treatment. (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2021 Category: Consumer Health News Source Type: news
View: Seven steps to reduce the third coronavirus wave to just a bout of common cold
"We should singularly focus on how to vaccinate 64 crore people quickly. I trust our government under the leadership of the PM will arrange an adequate number of vaccines. Next, if vaccination becomes a community effort, we can vaccinate 1 crore Indians every day." says Devi Shetty in the article. (Source: The Economic Times)
Source: The Economic Times - June 14, 2021 Category: Consumer Health News Source Type: news
Can you still catch a cold in summer? Why the common cold is back
COLDS seem to have disappeared since the start of the pandemic... but is the common cold coming back? Can you catch a cold in summer? (Source: Daily Express - Health)
Source: Daily Express - Health - June 2, 2021 Category: Consumer Health News Source Type: news
Antibody from cold can neutralize COVID-19 and could lead to vaccine against all coronaviruses
A new study from the Scripps Research Institute, in La Jolla, California, found higher levels of antibodies generated during the common cold in COVID survivors than in those never infected. (Source: the Mail online | Health)
Source: the Mail online | Health - May 31, 2021 Category: Consumer Health News Source Type: news
German scientists claim they have figured out why some Covid vaccines cause blood clots
Ellie Peacock (pictured) suffered blood clots after getting a jab. Researchers at Goethe-University of Frankfurt say the problem lies in a common cold virus used so the vaccine can enter the body. (Source: the Mail online | Health)
Source: the Mail online | Health - May 27, 2021 Category: Consumer Health News Source Type: news
German scientists say they can help improve Covid vaccines to prevent blood clots
AstraZeneca and Johnson& Johnson jabs have caused rare blood clots but scientists say they can be redesigned to avoid problemCoronavirus – latest updatesSee all our coronavirus coverageA team of German scientists believe that they have worked out whysome people given the AstraZeneca andJohnson& Johnson vaccines against Covid-19 develop blood clots – and claim they can tell the manufacturers how to improve the vaccine to avoid it.The key is in the adenovirus – the common cold virus that is used to deliver the spike protein of the coronavirus into the body, say Rolf Marschalek, a professor at Goethe university ...
Source: Guardian Unlimited Science - May 26, 2021 Category: Science Authors: Sarah Boseley Health editor Tags: Coronavirus UK news AstraZeneca Science Pharmaceuticals industry Source Type: news
European Commission approves PONVORYTM (ponesimod), a Once Daily, Oral Therapy for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis with Active Disease Defined by Clinical or Imaging Features
BEERSE, BELGIUM, May 24, 2021 – Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced today that the European Commission (EC) has approved PONVORY (ponesimod) for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease defined by clinical or imaging features.[4] “Relapsing multiple sclerosis is an unpredictable and complex disease that can present very differently from individual to individual, placing a heavy burden on the patient and their loved ones,” said Professor Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath, Professor of Neurology at Quee...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
COVID-19 could become like common cold in future, study suggests
The research, published in the journal Viruses, makes this likely prediction based on mathematical models that incorporate lessons learned from the current pandemic on how our body's immunity changes over time. (Source: The Economic Times)
Source: The Economic Times - May 21, 2021 Category: Consumer Health News Source Type: news
Immune genetics and previous common cold infections might help protect Japan from COVID-19
(Fujita Health University) By meta-analysis, experimentally determined COVID-19 virus T cell epitopes were compared with sequences of common cold coronaviruses (CCCoVs). Only one CCCoV-matching epitope was repeatedly identified as highly immunogenic, namely the CD8+ T cell epitope VYIGDPAQL ( " VYI " peptide) if presented by the MHC class I allele HLA-A*24:02. Approximately 60% of Japanese individuals carry this allele, which in combination with previous CCCoV infections might help explain the surprisingly low prevalence of COVID-19 in Japan. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2021 Category: Infectious Diseases Source Type: news
Will COVID-19 eventually become just a seasonal nuisance?
(University of Utah Health) Within the next decade, the novel coronavirus responsible for COVID-19 could become little more than a nuisance, causing no more than common cold-like coughs and sniffles. That possible future is predicted by mathematical models that incorporate lessons learned from the current pandemic on how our body's immunity changes over time. Scientists at the University of Utah carried out the research, now published in the journal Viruses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 20, 2021 Category: International Medicine & Public Health Source Type: news
The facts about zinc, the common cold and covid-19
The mineral has been popular during the pandemic, but scientific evidence is scant. Keep these five points in mind before you decide to use it. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 17, 2021 Category: Consumer Health News Authors: Sally Wadyka Source Type: news
Cold vs. allergies during COVID-19 pandemic
When it comes to the common cold, allergies and COVID-19, overlapping symptoms can be confusing. In this Q&A, Dr. Arveen Bhasin, a Mayo Clinic allergist and immunologist, provides some clarity by comparing and contrasting the signs and symptoms of these conditions: What are allergy symptoms?Allergy symptoms can affect the nose, sinuses and lungs. These symptoms [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 11, 2021 Category: Databases & Libraries Source Type: news
Tainted batches of Russia's Sputnik V Covid vaccine sent to Brazil carried a live version of a common cold-causing virus, the South...
Brazil says Russian Covid vaccine carried live cold virus (Source: Reuters: Health)
Source: Reuters: Health - April 28, 2021 Category: Consumer Health News Source Type: news
